Previously, Zhou et al. (2009) found that PDIA3 expression was decreased by PDIA3 siRNA in human breast cancer cells, but this inhibitory effect was abolished by a p38MAPK-specific inhibitor (SB203580), suggesting that p38MAPK is involved in the regulation of PDIA3 expression. This evidence concerns the gene PDIA3 and breast carcinoma.